Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 357 for “"RANKL"”.

  1. RANKL From Osteocytes Contributes to Periodontal Bone Loss

    … The ligand for the receptor activator of NF-κB (RANKL) induces the differentiation of osteoclasts, resulting in periodontal bone loss. The role of osteocytes in periodontal bone loss was investigated in this study. Transgenic mice expressing RANKL under the control of dentin matrix protein 1 …

    penn Repository record for RANKL From Osteocytes Contributes to Periodontal Bone Loss (opens in a new tab)

  2. RANKL and Osteoprotegerin Levels in Response to Orthodontic Forces

    … activator nuclear factor kappa B ligand (RANKL)—is critical for osteoclastogenesis, and osteoprotegerin (OPG) is a decoy ligand that competitively inhibits RANKL. A higher RANKL/OPG ratio is associated with areas of bone resorption, while a lower ratio occurs in areas of bone deposition …

    tenn-hsc Repository record for RANKL and Osteoprotegerin Levels in Response to Orthodontic Forces (opens in a new tab)

  3. Modulation of RANKL and Osteoprotegerin in Adolescents Using Orthodontic Forces

    … activator nuclear factor kappa B ligand (RANKL)--is critical for osteoclastogenesis, and osteoprotegerin (OPG) is a decoy ligand that competitively inhibits RANKL. A higher RANKL/OPG ratio is associated with areas of bone resorption, while a lower ratio occurs in areas of bone deposition …

    tenn-hsc Repository record for Modulation of RANKL and Osteoprotegerin in Adolescents Using Orthodontic Forces (opens in a new tab)

  4. Prevention of rebound bone loss following withdrawal of RANKL inhibition

    Denosumab is a potent inhibitor of RANKL-mediated osteoclast formation and activity, increasing BMD and reducing fracture risk. This has revolutionised treatment of osteoporosis and other skeletal conditions where suppression of bone resorption is required. However, discontinuation leads to a …

    unsw Repository record for Prevention of rebound bone loss following withdrawal of RANKL inhibition (opens in a new tab) Embargoed

  5. B lymphocyte RANKL enhances periodontal disease in type 2 diabetes

    … activator of nuclear factor kappa-B ligand (RANKL), which is a key element for osteoclastogenesis and periodontal related bone loss. Previous studies have looked at PD or T2D but not together within the context of inflammation. To further understand the impact of T2D potentiated periodontal …

    bu Repository record for B lymphocyte RANKL enhances periodontal disease in type 2 diabetes (opens in a new tab)

  6. Effect RANKL Produced by Periodontal Ligament Cells on Orthodontic Tooth Movement

    … Receptor activator of nuclear factor-κB ligand (RANKL) is essential for osteoclast formation and differentiation. Several cell types have been reported to be capable of producing RANKL. We are interested in whether there is a dominant cell type which RANKL production is critical in generating …

    penn Repository record for Effect RANKL Produced by Periodontal Ligament Cells on Orthodontic Tooth Movement (opens in a new tab)

  7. Μελέτη του ρόλου του γονιδίου RANKL στην Παθογένεια της Πνευμονικής Ίνωσης

    … της. Πρόσφατα βρέθηκε η έκφραση των γονιδίων RANKL/RANK/OPG σε συγκεκριμένα κύτταρα ιστών ποντικών με πνευμονική ίνωση και ο ρόλος της αναλογίας RANKL/OPG στην ασθένεια. Ο βασικός ρόλος των μορίων αυτών είναι η ρύθμιση του οστικού μεταβολισμού. H RANKL (receptor activator of NF-kB ligand) …

    athens Repository record for Μελέτη του ρόλου του γονιδίου RANKL στην Παθογένεια της Πνευμονικής Ίνωσης (opens in a new tab)

  8. Μελέτη του παθογενετικού ρόλου της κυτταροκίνης RANKL σε διαγονιδιακά ζωικά πρότυπα

    Receptor activator of NF-κBligand (RANKL) plays a key role in osteoclast-induced bone resorption across a range of degenerative bone diseases, and its specific inhibition has been recently approved as a treatment for women with postmenopausal osteoporosis at high or increased risk of fracture. In …

    greece Repository record for Μελέτη του παθογενετικού ρόλου της κυτταροκίνης RANKL σε διαγονιδιακά ζωικά πρότυπα (opens in a new tab)

  9. An investigation into the role of RANKL and sclerostin in dentoalveolar ankylosis

    … a major source of receptor activator of NF-κβ (RANKL) which is essential for osteoclastogenesis. This project aims to investigate the expression of RANKL and sclerostin in a rat model of dentoalveolar ankylosis induced by a hypothermal insult. The null hypothesis is that an applied cold insult …

    adelaide Repository record for An investigation into the role of RANKL and sclerostin in dentoalveolar ankylosis (opens in a new tab)

  10. Μελέτη του παθοφυσιολογικού ρόλου της πρωτεΐνης RANKL στον μαστικό αδένα διαγονιδιακών ποντικών

    … and the primary cause of death in women. RANKL (Receptor Activator of Nuclear Factor κB Ligand) has been identified as the main mediator of mammary gland development by progesterone during pregnancy, and recent data implicate it in hormone-induced breast cancer. This doctoral thesis …

    greece Repository record for Μελέτη του παθοφυσιολογικού ρόλου της πρωτεΐνης RANKL στον μαστικό αδένα διαγονιδιακών ποντικών (opens in a new tab)

  11. Μελέτη του συμπλέγματος rankl / οστεοπροτεγερίνης και ορμονικών παραμέτρων σε αιμοκαθαιρόμενους νεφροπαθείς ασθενείς

    … to the pathogenesis of renal bone disease. RANKL/OPG complex is one of the major modulators of bone remodelling and appears to mediate the effects of a number of humoral factors related to the development of renal osteodystrophy. The aim of the present study was the evaluation of RANKL/OPG …

    greece Repository record for Μελέτη του συμπλέγματος rankl / οστεοπροτεγερίνης και ορμονικών παραμέτρων σε αιμοκαθαιρόμενους νεφροπαθείς ασθενείς (opens in a new tab)

  12. In vitro cell models of vascular calcification: integrative roles for RANKL and TRAIL

    … namely receptor-activator of NF-κB ligand (RANKL) and tumour necrosis factor-related apoptosis-inducing ligand (TRAIL), interact with each other to regulate the calcification process. Whilst it is clear that RANKL promotes VC, in part via endothelial paracrine signalling, the precise role of …

    dcu Download PDF for In vitro cell models of vascular calcification: integrative roles for RANKL and TRAIL (opens in a new tab)

  13. Statins Regulate IL-1β - Induced RANKL and OPG Production by Human Gingival Fibroblasts

    … first one, receptor activator for NF- kB ligand (RANKL) is expressed on hematopoetic stromal cells and periosteal osteoblasts as well as on HGF and PDL cells. RANKL interacts with its corresponding receptor, RANK, on mononucleated osteoclast precursors and induces their activation to multinuclear …

    tenn-hsc Repository record for Statins Regulate IL-1β - Induced RANKL and OPG Production by Human Gingival Fibroblasts (opens in a new tab)

  14. Wnt Secretion Proteins Modulate RANKL-Induced Expression of Aire in Thymic Epithelial Cells

    … developing thymocytes and instead use exogenous RANKL to drive TEC specific maturation, while simultaneously culture the TECs with different Wnt proteins. Our results show that the Wnt antagonist, Sfrp-1, and the Wnt ligand, Wnt-5b, interfere with RANKL-induced maturation as demonstrated by a …

    cuny Repository record for Wnt Secretion Proteins Modulate RANKL-Induced Expression of Aire in Thymic Epithelial Cells (opens in a new tab)

  15. Estudo da associação dos genes RANk, RANKL e OPG com a osteopatia diabética

    … de RNAm e os polimorfismos dos genes RANK, RANKL e OPG de crianças, adolescentes e adultos jovens com DM1, bem como estudar a associação dos mesmos com o desenvolvimento de alterações no metabolismo ósseo.No total, foram incluídos no estudo 119 crianças e adolescentes com DM1 e 161 …

    brazil-ufrn Repository record for Estudo da associação dos genes RANk, RANKL e OPG com a osteopatia diabética (opens in a new tab)

  16. Μελέτη RANKL-επαγόμενων παθογενετικών μηχανισμών σε γενετικά ζωικά πρότυπα και νέες θεραπευτικές προσεγγίσεις

    … diseases, such as osteoporosis. The cytokine RANKL(Receptor Activator of Nuclear Factor kB Ligand), a TNF superfamily member(Tumor Necrosis Factor), is the main mediator in the process of bone resorption as itinduces differentiation, survival and activity of osteoclasts. As trimer RANKL …

    greece Repository record for Μελέτη RANKL-επαγόμενων παθογενετικών μηχανισμών σε γενετικά ζωικά πρότυπα και νέες θεραπευτικές προσεγγίσεις (opens in a new tab)

Page 1 of 18